Skip to content

A Comparison Between 0.5 Percentage Bupivacaine and 0.5 Percentage Ropivacaine with Dexamethasone as an Adjuvant in Supraclavicular Brachial Plexus Block.

A Comparative Study Between 0.5 Percentage Bupivacaine and 0.5 Percentage Ropivacaine with Dexamethasone as an Adjuvant in Supraclavicular Brachial Plexus Block. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089520
Enrollment
60
Registered
2025-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: BUPIVACAINE WITH DEXAMETHASONE: 28ml of 0.5% Bupivacaine along with 2ml of Dexamethasone was administered in Supraclavicular Brachial Plexus Block. Control Intervention1: ROPIVACAINE WI

Sponsors

Priyanka Balaji Wadikar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA grade 1 or 2 fit patients 2.Patients aged between 18-60 years of age 3.Both Male and Female gender 4.Patients posted for upper limb surgeries below shoulder 5.Hemodynamically stable patients with all routine investigations within normal limits. 6.Written informed consent from the concerned patients.

Exclusion criteria

Exclusion criteria: 1.Patients with ASA grade3 and above physical status. 2.Known allergy or contraindication to either bupivacaine or ropivacaine. 3.Patients with bleeding disorders and those on anticoagulant therapy 4.pre-existing sensory or motor deficits in the upper extremity. 5.History of neurological or psychiatric disorders affecting perception or cooperation 6.Pregnant women 7.Patients with significant comorbidities that could affect the safety of the procedure

Design outcomes

Primary

MeasureTime frame
To evaluate Onset of Sensory and Motor Blockade And to Assess Duration of Sensory and Motor blockade And to compare Postoperative Pain controlTimepoint: Baseline, 5min, 10min, 15min, 30min, End of Surgery, 2 Hours after Surgery, 4 Hours after Surgery, 6 Hours after Surgery, 8 Hours after Surgery, 10 Hours after Surgery, 12 Hours after Surgery

Secondary

MeasureTime frame
To Assess of Hemodynamic response And to examine the Incidence of Adverse EventsTimepoint: To monitor HR,BP,SPO2 At 0 min ,5min,10 min,15 min,30min,2hrs after surgery 4 hrs after surgery,6hrs after surgery,8hrs after surgery,10hrs after surgery,12hrs after surgery

Countries

India

Contacts

Public ContactDr Shahbaz Hasnain

Dr. D.Y. Patil Medical College, Hospital and Research Centre

shahbazhsnn@gmail.com9764621253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026